Rifaximin Treatment Is Associated With Reduced Risk of Cirrhotic Complications and Prolonged Overall Survival in Patients Experiencing Hepatic Encephalopathy

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization

American Journal of Gastroenterology
HepatologyGastroenterology
2014English

Safety, Efficacy, and Patient Acceptability of Rifaximin for Hepatic Encephalopathy

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2014English

Letter: Nutritional Benefits of Rifaximin in Cirrhotic Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients With Acute Variceal Bleeding

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia

Journal of Clinical Medicine Research
2019English

The Impact of Rifaximin-Α on the Hospital Resource Use Associated With the Management of Patients With Hepatic Encephalopathy: A Retrospective Observational Study (IMPRESS)

Frontline Gastroenterology
HepatologyGastroenterology
2017English

Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials

Journal of Clinical and Experimental Hepatology
Hepatology
2017English

High-Dose Glucocorticoids for the Treatment of Ipilimumab-Induced Hypophysitis Is Associated With Reduced Survival in Patients With Melanoma

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy